NCT04586946View on ClinicalTrials.gov

FIBRotic Interstitial Lung Disease and Nocturnal OXygen

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

May 30, 2021

Study Completion Date

May 30, 2021

Conditions
Idiopathic Pulmonary FibrosisObstructive Sleep ApneaSleep DisturbanceSleep Hypoventilation
Trial Locations (2)

SE19RT

Guy's and St Thomas' NHS Foundation Trust, London

sw36np

Royal Brompton Hospital, London

All Listed Sponsors
collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT04586946 - FIBRotic Interstitial Lung Disease and Nocturnal OXygen | Biotech Hunter | Biotech Hunter